Guinea-Bissau vs Liberia: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Guinea-Bissau
- Liberia
How they compare
Liberia currently reports 1,934 deaths against 1,774 deaths in Guinea-Bissau, a difference of 160 deaths.
That makes Liberia's figure about 1.1 times Guinea-Bissau's.
The two have swapped places 6 times across 35 shared years of data; in 1990 it was Liberia ahead.
Guinea-Bissau ranks 61st and Liberia ranks 60th of 157 countries.
Across the 4 decades both report, Guinea-Bissau averaged higher in 1 and Liberia in 2.
Head to head by decade
| Decade | Guinea-Bissau | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 130.35 deaths | 158.04 deaths | 27.68 deaths | Liberia |
| 2010s | 1,076 deaths | 977.16 deaths | 99.21 deaths | Guinea-Bissau |
| 2020s | 1,690 deaths | 1,790 deaths | 100.08 deaths | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Guinea-Bissau or Liberia?
- Liberia, at 1,934 deaths against 1,774 deaths in Guinea-Bissau as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Guinea-Bissau and Liberia?
- 160 deaths, with Liberia ahead.
- How many years of comparable data are there for Guinea-Bissau and Liberia?
- 35 years are reported by both, from 1990 to 2024.
- How do Guinea-Bissau and Liberia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Guinea-Bissau ranks 61st and Liberia ranks 60th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.